Full metadata record
DC FieldValueLanguage
dc.creatorQuiroga, J. (Jorge)-
dc.creatorZozaya, J.M. (José Manuel)-
dc.creatorLabarga, P. (Pablo)-
dc.creatorRodriguez-Ortigosa, C.M. (Carlos M.)-
dc.creatorMilazzo, A. (Alfredo)-
dc.creatorPrieto, J. (Jesús)-
dc.date.accessioned2012-10-03T12:35:31Z-
dc.date.available2012-10-03T12:35:31Z-
dc.date.issued1991-
dc.identifier.citationQuiroga J, Zozaya JM, Labarga P, Rodriguez-Ortigosa CM, Milazzo A, Prieto J. Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide. J Hepatol 1991 Mar;12(2):170-175.es_ES
dc.identifier.issn1600-0641-
dc.identifier.urihttp://hdl.handle.net/10171/23287-
dc.description.abstractThe influence of prostaglandins on renal function changes induced by furosemide was analyzed in 21 non-azotemic cirrhotic patients with ascites. Patients were studied in two periods of 120 min immediately before and after furosemide infusion (20 mg, ev). Furosemide caused an increase in creatinine clearance in 15 patients (group A: 99 +/- 7 vs. 129 +/- 5 ml/min; mean +/- S.E.) and a reduction in the remaining six (group B: 102 +/- 13 vs. 71 +/- 9 ml/min). Parallel changes were observed in the urinary excretion of 6-Keto-prostaglandin-F1 alpha (metabolite of renal prostacyclin) which augmented after furosemide in 14 of the 15 patients from group A (478 +/- 107 vs. 1034 +/- 159 pg/min, p less than 0.001) and decreased in all patients from group B (1032 +/- 240 vs. 548 +/- 136 pg/min, p less than 0.05). In contrast, the urinary excretion of prostaglandin E2 was stimulated by furosemide in all patients (group A, 92 +/- 19 vs. 448 +/- 60 pg/min, p less than 0.001; and group B, 209 +/- 63 vs. 361 +/- 25 pg/min, p less than 0.05). In all of the patients furosemide-induced changes (post- minus pre-furosemide values) in creatinine clearance were closely correlated in a direct and linear fashion with those in 6-Keto-prostaglandin-F1 alpha (r = 0.74; p less than 0.001). These changes were associated with a higher furosemide-induced natriuresis in group A than in group B (641 +/- 68 vs. 302 +/-- 46 mumol/min, p less than 0.001.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectEpoprostenol/physiologyes_ES
dc.subjectFurosemide/therapeutic usees_ES
dc.subjectKidney/physiopathologyes_ES
dc.subjectLiver Cirrhosis/drug therapyes_ES
dc.titleRenal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemidees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.driverinfo:eu-repo/semantics/articlees_ES

Files in This Item:
File: 
JHepatol1991_12_170.pdf
Description: 
Size: 
374,37 kB
Format: 
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.